Hair Loss Diagnostic Triage / 脱发鉴别分诊

Definition

Hair-loss diagnostic triage is a framework for using onset, distribution, triggers, shaft caliber, pull testing, dermoscopy, associated eyebrow or scalp changes, and sometimes biopsy to separate superficially similar causes before choosing treatment.

Current Synthesis

The two sources distinguish hair-loss pathways by pattern, tempo, triggers, family history, scalp findings, and specialist examination rather than treating a daily shed count as a diagnosis. VOL.80 focuses on women: female-pattern androgenetic alopecia is described as progressive thinning and increasing variation in hair caliber, often across the crown or central part but sometimes with frontal or frontotemporal recession. Telogen effluvium is linked to a preceding stressor such as childbirth, rapid weight change, poor nutrition, major illness or surgery, anxiety, or sleep disruption and may improve when the trigger resolves.

Diffuse alopecia areata can also produce sudden widespread loss but belongs to an autoimmune pathway and may require biopsy when the distinction remains unclear. Frontal fibrosing alopecia is presented as a more recognizable scarring pattern involving frontal recession, eyebrow loss, and isolated retained hairs, especially after menopause. These descriptions guide care questions; they do not turn a mirror check or pull test into a diagnosis.

VOL.62 independently reinforces androgenetic, alopecia-areata, telogen, and postpartum branches while adding family history, male and female pattern differences, traction loss, and the distinction between medical dermoscopy and sales-led salon testing. Its “100 hairs per day” heuristic is kept subordinate to density trend, distress, distribution, and clinical context.

Key Claims

• Hair-loss pattern, tempo, density trend, and family history are more informative than the generic fact—or a heuristic count—of hairs falling out.
• Trigger history can support telogen effluvium but does not exclude autoimmune, patterned, scarring, nutritional, endocrine, or other causes.
• Progressive shaft miniaturization and caliber diversity support a patterned-loss branch that dermoscopy can help assess.
• A positive pull test indicates active shedding but does not by itself distinguish telogen effluvium from diffuse alopecia areata.
• Frontal recession with eyebrow loss or scarring features warrants qualified assessment rather than routine cosmetic self-treatment.
• Biopsy is an escalation tool for unresolved diagnostic uncertainty, not a universal first step.
• Persistent traction adds a mechanically induced pathway distinct from ordinary brushing; treatment selection should follow the likely diagnosis and patient context.

Evidence

• Patterned loss - VOL.80 describes crown thinning, widening central part, frontal recession, and frontotemporal-plus-crown patterns alongside increasing hair-caliber variation.
• Triggered shedding - VOL.80 connects telogen effluvium with childbirth, severe stress, insomnia, rapid weight loss, nutritional problems, surgery, and trauma.
• Autoimmune distinction - VOL.80 presents diffuse alopecia areata as a sudden autoimmune condition that can be difficult to distinguish without specialist assessment and sometimes biopsy.
• Scarring pattern - VOL.80 links frontal fibrosing alopecia with frontal recession, eyebrow loss, retained isolated hairs, and postmenopausal presentation.
• Test limits - VOL.80 uses pull testing as a screening clue and dermoscopy or biopsy as higher-resolution inputs rather than treating any one test as sufficient.
• Trend and heredity - VOL.62 routes sustained density decline, patterned thinning, and family history to dermatologic assessment rather than requiring exact daily counting.
• Traction and commercial testing - VOL.62 adds persistent pulling as a cause and distinguishes qualified hair/scalp examination from salon sales interpretation.

Counterevidence & Qualifications

This framework comes from two structured podcast summaries, not a validated diagnostic rule. Shed-count and pull-test thresholds, disease labels, age associations, causal triggers, biopsy indications, and treatment implications remain source-scoped. Hair loss can also reflect medications, infection, endocrine or systemic illness, nutritional deficiency, hair-shaft breakage, or other conditions not fully developed in the sources. Sudden, patchy, painful, inflamed, scarring, eyebrow-associated, rapidly progressive, persistent, or systemic-symptom-associated loss warrants qualified assessment.

What Changed

• Added density trend, family history, sex-pattern differences, traction loss, and the limit of daily shed-count heuristics.
• Added the distinction between medical dermoscopy and commercially interpreted salon testing.

Related Concepts

• Hair Loss And Follicle Cycle - biological model for growth, rest, shedding, miniaturization, and recovery.
• Minoxidil / 米诺地尔 - treatment whose suitability depends on the diagnostic branch and patient context.
• Medical Knowledge Boundary - reason public symptom descriptions cannot establish an individual diagnosis.
• Gendered Hair Regulation - social pressure that can intensify distress without clarifying cause.
• 女性美貌自我监控 / Female Beauty Self-Surveillance - appearance-monitoring context that can amplify attention to part width and hairline change.
• Hair and Scalp Care Boundary / 头发与头皮护理边界 - separates routine hygiene and shaft protection from diagnosis and follicle treatment.